BETTY FALECKI: Open Payments
NPI 1427666056 · PORT HURON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$367 in 18 payments from 15 companies in 2025. Trend: 2023 $500 · 2024 $475 · 2025 $367
Food & beverage: $367
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 2 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Orexo US, Inc. | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Biogen, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $21 |
Products named: VERQUVO, XIFAXAN, CAPLYTA, VPRIV, Zubsolv, FANAPT, SKYCLARYS, Auvelity.
Industry payments across MI — which companies pay providers there.
